[go: up one dir, main page]

ES2129381T1 - Formulaciones orales de ciclosporina. - Google Patents

Formulaciones orales de ciclosporina.

Info

Publication number
ES2129381T1
ES2129381T1 ES96926214T ES96926214T ES2129381T1 ES 2129381 T1 ES2129381 T1 ES 2129381T1 ES 96926214 T ES96926214 T ES 96926214T ES 96926214 T ES96926214 T ES 96926214T ES 2129381 T1 ES2129381 T1 ES 2129381T1
Authority
ES
Spain
Prior art keywords
cyclosporine
formulations
oral formulations
solvent
dioles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES96926214T
Other languages
English (en)
Inventor
Moo J Cho
Ralph E Levy
Philippe J Pouletty
H Robert Floc
Christian Merle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Sangstat Medical Corp
Original Assignee
University of North Carolina at Chapel Hill
Sangstat Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/519,689 external-priority patent/US5834017A/en
Priority claimed from US08/620,021 external-priority patent/US5766629A/en
Priority claimed from US08/622,516 external-priority patent/US5827822A/en
Application filed by University of North Carolina at Chapel Hill, Sangstat Medical Corp filed Critical University of North Carolina at Chapel Hill
Publication of ES2129381T1 publication Critical patent/ES2129381T1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE FACILITAN FORMULACIONES ORALES MEJORADAS DE CICLOSPORINA QUE TIENEN UNA ALTA BIODISPONIBILIDAD Y PUEDEN ADMINISTRARSE EN CAPSULAS DURAS O EN NANOPARTICULAS. EN ESTAS FORMULACIONES, SE SUMINISTRA CICLOSPORINA EN UN VEHICULO ACEPTABLE ORALMENTE QUE INCLUYE AL MENOS UN SOLVENTE DE ALCANOL DE 2 A 3 ATOMOS DE CARBONO EN COMBINACION CON AL MENOS UN SURFACTANTE NO IONICO. ESTAS FORMULACIONES PUEDEN INCLUIR ADEMAS UN COSOLVENTE, INCLUYENDO LOS COSOLVENTES DE INTERES ACIDOS GRASOS Y DIOLES. ESTAS FORMULACIONES TIENEN UTILIDAD EN LA TERAPIA INMUNOSUPRESORA.
ES96926214T 1995-08-25 1996-07-31 Formulaciones orales de ciclosporina. Pending ES2129381T1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/519,689 US5834017A (en) 1995-08-25 1995-08-25 Oral cyclopsporin formulations
US08/620,021 US5766629A (en) 1995-08-25 1996-03-21 Oral cyclosporin formulations
US08/622,516 US5827822A (en) 1996-03-25 1996-03-25 Cyclosporin a formulations as nanoparticles

Publications (1)

Publication Number Publication Date
ES2129381T1 true ES2129381T1 (es) 1999-06-16

Family

ID=27414735

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96926214T Pending ES2129381T1 (es) 1995-08-25 1996-07-31 Formulaciones orales de ciclosporina.

Country Status (26)

Country Link
EP (1) EP0789561B1 (es)
JP (1) JP3009742B2 (es)
KR (1) KR100294935B1 (es)
CN (1) CN1164828A (es)
AR (1) AR001985A1 (es)
AT (1) ATE263550T1 (es)
AU (1) AU709548B2 (es)
BG (1) BG62875B1 (es)
BR (1) BR9606603A (es)
CA (1) CA2202887A1 (es)
CZ (1) CZ124897A3 (es)
DE (2) DE789561T1 (es)
ES (1) ES2129381T1 (es)
GE (1) GEP20012547B (es)
HU (1) HUP9801052A3 (es)
IL (1) IL120673A0 (es)
IS (1) IS4460A (es)
MX (1) MX9702809A (es)
NO (1) NO971890L (es)
NZ (1) NZ313899A (es)
PL (1) PL319898A1 (es)
RO (1) RO119815B1 (es)
SI (1) SI9620014A (es)
SK (1) SK53697A3 (es)
TW (1) TW460287B (es)
WO (1) WO1997007787A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
SI0969856T1 (en) * 1997-03-12 2005-06-30 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
US6673768B1 (en) 1997-10-16 2004-01-06 Board Of Regents, The University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
US7026290B1 (en) 1998-12-30 2006-04-11 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosprin
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
DE60233150D1 (de) 2001-10-19 2009-09-10 Isotechnika Inc Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
CN103120653B (zh) 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
CA2685118C (en) 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
JP5640079B2 (ja) 2009-05-18 2014-12-10 シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ 油滴含有組成物
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
PT3215127T (pt) 2014-11-07 2021-02-10 Sublimity Therapeutics Ltd Composições que compreendem ciclosporina
CN104940132B (zh) * 2015-06-05 2018-02-27 河南牧翔动物药业有限公司 一种硫酸小檗碱口服液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
PT589843E (pt) * 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
SK164796A3 (en) * 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them

Also Published As

Publication number Publication date
AU6644196A (en) 1997-03-19
GEP20012547B (en) 2001-10-25
BG101443A (en) 1998-03-31
AU709548B2 (en) 1999-09-02
DE69632125T2 (de) 2004-09-16
HUP9801052A2 (hu) 1998-09-28
BR9606603A (pt) 1997-09-30
IS4460A (is) 1997-04-08
CZ124897A3 (en) 1997-09-17
RO119815B1 (ro) 2005-04-29
PL319898A1 (en) 1997-09-01
KR100294935B1 (ko) 2001-07-12
NZ313899A (en) 2000-03-27
NO971890D0 (no) 1997-04-24
JP3009742B2 (ja) 2000-02-14
DE69632125D1 (de) 2004-05-13
MX9702809A (es) 1998-02-28
TW460287B (en) 2001-10-21
HUP9801052A3 (en) 1998-12-28
KR970706803A (ko) 1997-12-01
EP0789561A1 (en) 1997-08-20
SI9620014A (sl) 1998-04-30
JPH10509462A (ja) 1998-09-14
DE789561T1 (de) 1999-06-10
IL120673A0 (en) 1997-08-14
CN1164828A (zh) 1997-11-12
WO1997007787A1 (en) 1997-03-06
SK53697A3 (en) 1997-10-08
EP0789561B1 (en) 2004-04-07
EP0789561A4 (en) 1998-12-02
ATE263550T1 (de) 2004-04-15
HK1001956A1 (en) 1998-07-24
NO971890L (no) 1997-04-24
BG62875B1 (bg) 2000-10-31
CA2202887A1 (en) 1997-03-06
AR001985A1 (es) 1998-01-07

Similar Documents

Publication Publication Date Title
ES2129381T1 (es) Formulaciones orales de ciclosporina.
AR013710A1 (es) Formulaciones orales de ciclosporina
AR012287A1 (es) Preparado de medicamento para la administracion peroral y uso de portadores, especialmente de polietilenglicol-660-12-hidroxiestearato yetanol o 1,2-propilenglicol
ES2168271T3 (es) Composiciones farmaceuticas que contienen ciclosporinas.
NO20014719D0 (no) Orale farmasöytiske preparater inneholdende lang-kjedete triglyserider og lipofile overflateaktive midler
DE69804624D1 (de) Selbstemulgierende formulierung enthaltend lipophile verbindungen
GB2314508A (en) Diamide-dicarboxylic acid microspheres
HUP0101080A2 (hu) Ciklosporint vagy egy makrolidet tartalmazó emulzió előkoncentrátumok
DE19581805T1 (de) Pharmazeutische Zusammensetzungen
FR2405711A1 (fr) Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium
DE59407239D1 (de) Pharmazeutische präparate für schwerlösliche wirkstoffe
BR9811058A (pt) Formulação auto-emulsificante para compostos lipofìlicos
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
Tsong et al. High Field Effects Useful for Atomic Mauipulatious
JPS5679626A (en) Semi-solid medicine
KR960021036A (ko) 콜치신을 유효성분으로 함유하는 항간독성 조성물 및 그 제조방법